全球定序耗材市场规模、份额、趋势及成长分析报告（2026-2034）

预计定序耗材市场规模将从 2025 年的 112.9 亿美元成长到 2034 年的 742.1 亿美元，2026 年至 2034 年的复合年增长率为 23.27%。

随着基因组研究和个人化医疗的进步不断推动对定序技术的需求，定序耗材市场预计将迎来显着成长。定序耗材包括用于DNA和RNA定序过程的试剂、试剂盒和其他材料，对于研究、临床诊断和生物技术领域的各种应用至关重要。随着高通量定序和基因组分析需求的持续成长，定序耗材市场预计将大幅扩张。

定序技术和调查方法的进步在塑造定序耗材市场方面发挥关键作用。次世代定序(NGS) 和单细胞定序的创新提高了基因组分析的效率和准确性，使定序耗材对研究人员和医疗保健机构更具吸引力。此外，个人化医疗和标靶治疗的兴起也推动了对能够实现精准基因组分析和诊断的耗材的需求。随着製造商持续加大研发投入，新型耗材产品和应用的潜力将进一步推动定序耗材市场的成长。

此外，人们对健康和保健日益增长的关注正在影响定序耗材市场的格局。随着消费者和医疗保健专业人员寻求了解遗传易感性并进行相应治疗，对定序技术和耗材的需求不断增长。许多研究和临床检查室正在采用先进的定序方法，旨在改善患者照护和健康结果。将定序耗材整合到更广泛的医疗保健实践中将进一步提升其吸引力。随着市场的成熟，技术、健康趋势和消费者偏好的整合将成为成长的关键驱动力，使定序耗材成为现代基因组研究和诊断的重要组成部分。

目录

第一章 引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 绘製渗透率和成长前景图
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 市场问题
• 波特五力分析
• PESTLE分析

4. 全球定序耗材市场（依产品划分）

• 市场分析、洞察与预测
• 成套工具
• 试剂
• 配件

5. 全球定序耗材市场（依平台划分）

• 市场分析、洞察与预测
• 第一代定序耗材
• 第二代定序耗材
• 第三代定序耗材

6. 全球定序耗材市场（依应用领域划分）

• 市场分析、洞察与预测
• 癌症诊断
• 感染疾病诊断
• 生殖健康检查
• 药物基因体学
• 农业基因组学
• 其他的

7. 全球定序耗材市场（依最终用途划分）

• 市场分析、洞察与预测
• 製药和生物技术公司
• 医院和研究机构
• 学术研究机构
• 其他的

8. 全球定序耗材市场（依地区划分）

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第九章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商格局（基于现有资讯）
• 策略规划

第十章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Hoffmann-La Roche Ltd
  • Qiagen
  • Agilent Technologies
  • Millipore Sigma
  • Takara Bio Inc
  • Beckman Coulter Inc
  • Eurofins Genomics
  • Oxford Nanopore Technologies Ltd
  • Thermo Fisher Scientific Inc
  • BGI Genomics

The Sequencing Consumables Market size is expected to reach USD 74.21 Billion in 2034 from USD 11.29 Billion (2025) growing at a CAGR of 23.27% during 2026-2034.

The Sequencing Consumables market is poised for significant growth as advancements in genomic research and personalized medicine continue to drive demand for sequencing technologies. Sequencing consumables, which include reagents, kits, and other materials used in DNA and RNA sequencing processes, are essential for various applications in research, clinical diagnostics, and biotechnology. As the demand for high-throughput sequencing and genomic analysis continues to rise, the sequencing consumables market is expected to expand significantly.

Technological advancements in sequencing technologies and methodologies are playing a crucial role in shaping the Sequencing Consumables market. Innovations in next-generation sequencing (NGS) and single-cell sequencing are enhancing the efficiency and accuracy of genomic analysis, making sequencing consumables more appealing to researchers and healthcare providers. Additionally, the rise of personalized medicine and targeted therapies is driving demand for consumables that enable precise genomic profiling and diagnostics. As manufacturers continue to invest in research and development, the potential for new consumable products and applications will drive growth in the sequencing consumables market.

Moreover, the increasing focus on health and wellness is influencing the Sequencing Consumables market landscape. As consumers and healthcare professionals seek to understand genetic predispositions and tailor treatments accordingly, the demand for sequencing technologies and consumables is rising. Many research institutions and clinical laboratories are adopting advanced sequencing methods to enhance patient care and improve health outcomes. The integration of sequencing consumables into broader healthcare initiatives will further enhance their appeal. As the market matures, the convergence of technology, health trends, and consumer preferences will be key drivers of growth, positioning sequencing consumables as essential components in modern genomic research and diagnostics.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Kits
• Reagents
• Accessories

By Platform

• 1st Generation Sequencing Consumables
• 2nd Generation Sequencing Consumables
• 3rd Generation Sequencing Consumables

By Application

• Cancer Diagnostics
• Infectious Disease Diagnostics
• Reproductive Health Diagnostics
• Pharmacogenomics
• Agrigenomics
• Others

By End-use

• Pharmaceutical and Biotechnology Companies
• Hospitals and Laboratories
• Academic Research Institutes
• Others

COMPANIES PROFILED

• HoffmannLa Roche Ltd, Qiagen, Agilent Technologies, Millipore Sigma, Takara Bio Inc, Beckman Coulter Inc, Eurofins Genomics, Oxford Nanopore Technologies Ltd, Thermo Fisher Scientific Inc, BGI Genomics

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL SEQUENCING CONSUMABLES MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Accessories Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL SEQUENCING CONSUMABLES MARKET: BY PLATFORM 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Platform
• 5.2. 1st Generation Sequencing Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. 2nd Generation Sequencing Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. 3rd Generation Sequencing Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL SEQUENCING CONSUMABLES MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Cancer Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Infectious Disease Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Reproductive Health Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Pharmacogenomics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Agrigenomics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL SEQUENCING CONSUMABLES MARKET: BY END-USE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End-use
• 7.2. Pharmaceutical and Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Hospitals and Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Academic Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL SEQUENCING CONSUMABLES MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product
  • 8.2.2 By Platform
  • 8.2.3 By Application
  • 8.2.4 By End-use
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product
  • 8.3.2 By Platform
  • 8.3.3 By Application
  • 8.3.4 By End-use
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product
  • 8.4.2 By Platform
  • 8.4.3 By Application
  • 8.4.4 By End-use
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product
  • 8.5.2 By Platform
  • 8.5.3 By Application
  • 8.5.4 By End-use
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product
  • 8.6.2 By Platform
  • 8.6.3 By Application
  • 8.6.4 By End-use
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL SEQUENCING CONSUMABLES INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Hoffmann-La Roche Ltd
  • 10.2.2 Qiagen
  • 10.2.3 Agilent Technologies
  • 10.2.4 Millipore Sigma
  • 10.2.5 Takara Bio Inc
  • 10.2.6 Beckman Coulter Inc
  • 10.2.7 Eurofins Genomics
  • 10.2.8 Oxford Nanopore Technologies Ltd
  • 10.2.9 Thermo Fisher Scientific Inc
  • 10.2.10 BGI Genomics